Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002529867 | SCV000759533 | likely benign | Blau syndrome; Regional enteritis | 2024-05-12 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002261144 | SCV002542725 | uncertain significance | Autoinflammatory syndrome | 2020-03-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004957926 | SCV005457053 | uncertain significance | Inborn genetic diseases | 2024-08-19 | criteria provided, single submitter | clinical testing | The c.314C>T (p.A105V) alteration is located in exon 2 (coding exon 2) of the NOD2 gene. This alteration results from a C to T substitution at nucleotide position 314, causing the alanine (A) at amino acid position 105 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |